Details for New Drug Application (NDA): 009108
✉ Email this page to a colleague
NDA 009108 describes RAUVAL, which is a drug marketed by Pal Pak and is included in one NDA. Additional details are available on the RAUVAL profile page.
The generic ingredient in RAUVAL is rauwolfia serpentina root. There are eight drug master file entries for this compound. Additional details are available on the rauwolfia serpentina root profile page.
The generic ingredient in RAUVAL is rauwolfia serpentina root. There are eight drug master file entries for this compound. Additional details are available on the rauwolfia serpentina root profile page.
Summary for 009108
| Tradename: | RAUVAL |
| Applicant: | Pal Pak |
| Ingredient: | rauwolfia serpentina root |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
